Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggrenox for Hemodialysis Graft Patency
NCT00067119Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2003
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dipyridamole in kidney failure (ESRD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2003; status: completed.
02
Drugs
dipyridamole
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT00067119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067119.